Low molecular weight heparin synergistically enhances the efficacy of adoptive and anti-PD-1-based immunotherapy by increasing lymphocyte infiltration in colorectal cancer.
Yibo QuanJie HeQi ZouLiuxi ZhangQihui SunHongli HuangWanglin LiKeping XieFang WeiPublished in: Journal for immunotherapy of cancer (2023)
T cells. These results indicate that combining LMWH with an immunotherapy strategy presents a promising and safe approach for CRC treatment, especially in MSS tumors.